Utilization of the Community Popular Opinion Leader (C-POL) Model in Alabama
Community members within the treatment city will report: 1)engaging in fewer sexual risk practices; 2)significantly higher condom use; 3) significantly higher rates of STD care seeking (including STD screening behaviors); 4) fewer having STDs in the past 6 months; 5) significantly higher awareness scores regarding syphilis and other STDs, as compared with those in the comparison city.
Sexually Transmitted Diseases
Behavioral: Community-Popular Opinion Leader Model
Behavioral: Diffusion of Innovations
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Prevention
|Official Title:||Utilization of the Community Popular Opinion Leader (C-POL) Model to Achieve Syphilis Elimination in Alabama|
- Changes in syphilis morbidity in affected community
- Changes in risk behavior and health care seeking behavior
|Study Start Date:||October 2002|
|Estimated Study Completion Date:||July 2005|
The C-POL in Alabama project is and intervention study which sought to impact the health behaviors of community residents who live in zip codes that have high syphilis morbidity. The study is being implemented in Birmingham and Montgomery with shelter clients.
The intervention model used for this study is the Popular Opinion Leader (POL) model, which is effective at reducing new HIV infections. The intent of this study was to determine the effectiveness of a diffusion model (e.g. POL) at reducing syphilis infections in affected communities.
For the intervention, community members identified as popular opinion leaders were recruited and trained to share accurate information about syphilis transmission, symptoms, testing, treatment and prevention. Prior to intervention implementation and several times after, community members were given a survey and screened for syphilis as well as 2-3 additional STDs. During each assessment, cross-sections of the community members were sampled.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00260754
|United States, Alabama|
|University of Alabama, Birmingham|
|Birmingham, Alabama, United States, 35294-0022|
|Study Chair:||Samantha Williams, Ph.D.||CDC/NCHSTP/DSTDP/BIRB|
|Principal Investigator:||Diane Grimley, Ph.D.||University of Alabama at Birmingham|